Swiss Life Asset Management Ltd decreased its stake in Revvity Inc. (NYSE:RVTY – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,127 shares of the company’s stock after selling 6,972 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Revvity were worth $2,141,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. CYBER HORNET ETFs LLC bought a new position in shares of Revvity in the second quarter worth approximately $32,000. Cromwell Holdings LLC raised its position in shares of Revvity by 141.4% during the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after purchasing an additional 198 shares during the period. MUFG Securities EMEA plc bought a new stake in shares of Revvity during the 2nd quarter valued at $34,000. Headlands Technologies LLC bought a new stake in shares of Revvity during the 2nd quarter valued at $49,000. Finally, Smartleaf Asset Management LLC raised its position in shares of Revvity by 56.8% during the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock valued at $58,000 after purchasing an additional 250 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have recently commented on RVTY shares. Evercore raised their price objective on shares of Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research report on Tuesday, February 3rd. TD Cowen upped their price objective on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. JPMorgan Chase & Co. dropped their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Finally, Jefferies Financial Group upped their price objective on Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Four investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $107.73.
Revvity Trading Down 2.3%
Shares of RVTY stock opened at $94.19 on Friday. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The stock’s 50-day moving average price is $90.31 and its 200-day moving average price is $96.93. The stock has a market capitalization of $10.51 billion, a price-to-earnings ratio of 45.07, a price-to-earnings-growth ratio of 2.08 and a beta of 1.05.
Revvity (NYSE:RVTY – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million for the quarter, compared to analysts’ expectations of $704.07 million. During the same period in the previous year, the firm posted $1.01 earnings per share. The business’s revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities research analysts predict that Revvity Inc. will post 5.33 EPS for the current fiscal year.
Revvity Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is 13.40%.
Revvity Company Profile
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Featured Articles
- Five stocks we like better than Revvity
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
